Anti-PD-1 Antibody Combined With Pegaspargase in the Treatment of Advanced Stage NK/T-cell Lymphoma

NCT04096690 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Nasal Type Extranodal NK/T-Cell Lymphoma

Interventions

DRUG: Pegaspargase
DRUG: Anti-PD-1 monoclonal antibody

Sponsor

Ruijin Hospital